Skip to main content

Table 1 Primary conditions treated with medicinal cannabis

From: Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients

Primary conditions

Total: n (%)

Male: n (%)

Female: n (%)

Unspecified: n (%)

Total study population

2032

1271 (62.6%)

758 (37.3%)

3 (0.15%)

Chronic pain

598 (29.4%)

371 (62%)

227 (38%)

 

Mental health condition

548 (27%)

319 (58.2%)

228 (41.6%)

1 (0.2%)

Insomnia

198 (9.7%)

145 (73.2%)

53 (26.8%)

 

Arthritis/musculoskeletal

188 (9.3%)

112 (59.6%)

76 (40.4%)

 

PTSD

93 (4.6%)

59 (63.4%)

33 (35.5%)

1 (1.1%)

Headache

75 (3.7%)

44 (58.7%)

31 (41.3)

 

Gastrointestinal disorder

62 (3.1%)

34 (54.8%)

28 (45.2%)

 

Multiple sclerosis

45 (2.2%)

26 (57.8%)

19 (42.2%)

 

Other

38 (1.9%)

23 (60.5%)

15 (39.5%)

 

Cancer/leukemia

35 (1.7%)

24 (68.6%)

11 (31.4%)

 

Crohn’s disease

35 (1.7%)

27 (77.1%)

8 (22.9%)

 

Brain injury

24 (1.3%)

16 (66.7%)

8 (33.3%)

 

Epilepsy/seizure disorder

21 (1.0%)

18 (85.7%)

3 (14.3%)

 

Eating disorder

20 (1.0%)

10 (50%)

10 (50%)

 

Diabetes

16 (0.79%)

13 (81.3%)

3 (18.7%)

 

Movement disorder

10 (0.49%)

8 (80%)

1 (10%)

1 (10%)

AIDS/HIV

8 (0.39%)

7 (87.5%)

1 (12.5%)

 

Hepatitis

6 (0.30%)

6 (100%)

0 (0%)

 

Glaucoma

5 (0.25%)

5 (100%)

0 (0%)

 

Osteoporosis

4 (0.20%)

3 (75%)

1 (25%)

 

Skin condition

3 (0.15%)

1 (33.3%)

2 (66.7%)

Â